insiders

Bill Gurley's Stitch Fix insider buying is his first ever as a corporate insider. Gurley bought $3.1 million of Stitch Fix, Inc. (SFIX) shares on the open market, increasing his personal stake by 25% to 755,000 shares. The tech dealmaker's purchases come as SFIX short interest has...

Hudson Executive Capital disclosed on Monday that it bought 143,200 shares of USA Technology (USAT) at $4.46 along with call options giving the fund the right to buy another 1,250,000 shares of stock at $10. The call options expire on Jan. 17, 2020.

Intra-Cellular Therapies FDA news release on Sept. 10 appeared positive. The FDA informed the company that it will not schedule an Advisory Committee meeting in connection with its review of the company’s new drug application (NDA) for Lumateperone for the treatment of schizophrenia. All good, moving ahead,...

Cigna Insider Buying is a rarity. Only one corporate insider had bought shares of the giant health insurer on the open market since 2003. That changed dramatically on Monday, as Cigna (CI) CEO David Cordani disclosed the purchase of 32,509 shares of his company's stock at $155.17....

GE is another Enron, only worse. That's according to forensic accountant Harry Markopolos, famous for raising red flags about Bernie Madoff ’s Ponzi scheme before most anyone else had a clue. Markipolos released a report on Thursday claiming General Electric (GE) has been...

Donald Trump's insider buying history is short, but interesting, given the fact that the former corporate insider is now the 45th President of the United States. It was Monday, Sept. 15, 2008 at 3:08 PM when Donald J. Trump filed a Form 4...

Insiders buy market crashes, backing up the truck if their shares get cheap enough. The smartest fund managers can make their year -- even careers -- acquiring great companies at phenomenal bargains during market crashes. True market crashes are rare--black swans. But garden variety "panics" occur fairly...

Solid Biosciences' private placement featured investments by an all star list of top biotech institutional investors. Cambridge-based Solid Biosciences (SLDB) trades at 1/3 of its January 2018 IPO value. But based on the A-list biotech investors buying shares in the company's July 26 $60...

Twenty-two minutes after regular market hours closed on July 2, an Orbimed Advisors Form 4 relating to Corvus Pharmaceuticals Inc (CRVS) was posted on the SEC's website. The hedge fund, a 10%+ holder and insider in CRVS, disclosed that between June 27 and July 1 it...

Macerich insiders have bought a record $2.8 million of the retail mall developer's stock over the last two months as Macerich (MAC) shares hit seven year lows. A great story needs a great title. And what could be better than "Retail Apocalypse" to capture...